SARS-CoV-2-associated multisystem inflammatory syndrome in a child
DOI: 10.32364/2618-8430-2021-4-4-375-377
N.M. Nagovitsyna
Kama Children’s Medical Center, Naberezhnye Chelny, Russian Federation
The COVID-19 infection occurs much less commonly in children than in adults, presumably due to the predominance of asymptomatic variants. Nevertheless, single deaths by the COVID-19 were reported in children worldwide. Some of these deaths result from multisystem inflammatory syndrome (MIS) that develops at late stages or after the COVID-19. MIS is characterized by acute onset, steady fever, skin and mucosal damage, and multiorgan failure. Unlike the classic variant of Kawasaki disease, MIS is associated with more frequent shocks and a more severe course. This paper addresses a case report of MIS with a favorable course and outcome in a 7-year-old boy. Practitioners should be aware that severe intoxication and inflammation with increased inflammatory markers emerging at late stages or after respiratory infections are potential manifestations of MIS. In these cases, tests for the COVID-19 should be timely performed; if found, pathogenic therapy is promptly init iated. Taking into account the insufficient knowledge of the pathogenesis and the knowledge of the consequences of MIS associated with SARS-CoV-2, long-term follow-up monitoring is required.
Keywords: coronavirus infection, COVID-19, SARS-СoV-2, multisystem inflammatory syndrome, Kawasaki-like syndrome, Kawasaki-like disease.
For citation: Nagovitsyna N.M. SARS-CoV-2-associated multisystem inflammatory syndrome in a child. Russian Journal of Woman and Child Health. 2021;4(4):375–377 (in Russ.). DOI: 10.32364/2618-8430-2021-4-4-375-377.
About the author:
Natalya M. Nagovitsyna — Deputy Head Doctor for Pediatric Care, infectiologist, Kama Children’s Medical Center; 18, Academician Korolev str., Naberezhnye Chelny, 423812, Russian Federation; ORCID iD 0000-0001-6068-3884.
Contact information: Natalya M. Nagovitsyna, e-mail: Natalya.Nagovicyna@tatаr.ru.
Financial Disclosure: author has not a financial or property interest in any material or method mentioned.
There is no conflict of interests.
Received 06.10.2021.
Revised 29.10.2021.
Accepted 25.11.2021.
2. Namazova-Baranova Leyla S. Coronaviral Infection (COVID-19) in Children (Situation on April 2020). Pediatric pharmacology. 2020;17(2):85–94. DOI: 10.15690/pf.v17i2.2094 (in Russ.).
3. Starshinova A.A., Kushnareva E.A., Malkova A.M. et al. New Coronaviral Infection: Features of Clinical Course, Capabilities of Diagnostics, Treatment and Prevention in Adults and Children. Current Pediatrics. 2020;19(2):123–131 (in Russ.). DOI: 10.15690/vsp.v19i2.2105.
4. Methodical recommendations "Features of clinical manifestations and treatment of a disease caused by a new coronavirus infection (COVID-19) in children". Moscow, 07/03/2020. Version 2 (approved by the Ministry of Health of Russia) (in Russ.).
5. Toubiana J., Poirault C., Corsia A. et al. Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. DOI: 10.1136/bmj.m2094.
6. Ouldali N., Pouletty M., Mariani P. et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health. 2020;4(9):662–668. DOI: 10.1016/S2352-4642(20)30175-9.
7. Verdoni L., Mazza A., Gervasoni A. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–1778. DOI: 10.1016/S0140-6736(20)31103-X.
8. Cavallo F., Chiarelli F. An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise? Acta Biomed. 2020;91(3):e2020015. DOI: 10.23750/abm.v91i3.10305.
9. Koné-Paut I., Cimaz R. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic. RMD Open. 2020;6(2):e001333. DOI: 10.1136/rmdopen-2020-001333.
10. Santos B.S.D., Santos F.S.D., Ribeiro E.R. Clinical-Epidemiological Relation Between SARS-CoV-2 And Kawasaki Disease: An Integrative Literature. Rev Paul Pediatr. 2021;39:e2020217. DOI: 10.1590/1984-0462/2021/39/2020217.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать